149 related articles for article (PubMed ID: 23352344)
1. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston Keratoprosthesis.
Sivaraman KR; Hou JH; Allemann N; de la Cruz J; Cortina MS
Am J Ophthalmol; 2013 May; 155(5):814-22. PubMed ID: 23352344
[TBL] [Abstract][Full Text] [Related]
2. Retroprosthetic Membrane Formation in Boston Keratoprosthesis: A Case-Control-Matched Comparison of Titanium Versus PMMA Backplate.
Talati RK; Hallak JA; Karas FI; de la Cruz J; Cortina MS
Cornea; 2018 Feb; 37(2):145-150. PubMed ID: 29140862
[TBL] [Abstract][Full Text] [Related]
3. Anterior segment optical coherence tomography findings in type I Boston keratoprosthesis.
Silva LD; Santos A; Sousa LB; Allemann N; Oliveira LA
Arq Bras Oftalmol; 2018; 81(1):42-46. PubMed ID: 29538593
[TBL] [Abstract][Full Text] [Related]
4. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
5. Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston type I keratoprosthesis.
Qian CX; Hassanaly S; Harissi-Dagher M
Ophthalmology; 2015 Feb; 122(2):317-25. PubMed ID: 25264027
[TBL] [Abstract][Full Text] [Related]
6. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
7. International results with the Boston type I keratoprosthesis.
Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography.
Garcia JP; Ritterband DC; Buxton DF; De la Cruz J
Cornea; 2010 Sep; 29(9):1031-5. PubMed ID: 20517152
[TBL] [Abstract][Full Text] [Related]
9. Histopathological and immunohistochemical analysis of melt-associated retroprosthetic membranes in the Boston type 1 keratoprosthesis.
Hou JH; Sivaraman KR; de la Cruz J; Lin AY; Cortina MS
JAMA Ophthalmol; 2014 Sep; 132(9):1133-6. PubMed ID: 25010136
[TBL] [Abstract][Full Text] [Related]
10. Corneal Melt after Boston Keratoprosthesis: Clinical Presentation, Management, Outcomes and Risk Factor Analysis.
Bouhout S; Robert MC; Deli S; Harissi-Dagher M
Ocul Immunol Inflamm; 2018; 26(5):693-699. PubMed ID: 28080168
[TBL] [Abstract][Full Text] [Related]
11. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience.
Wang Q; Harissi-Dagher M
Am J Ophthalmol; 2014 Dec; 158(6):1297-1304.e1. PubMed ID: 25174898
[TBL] [Abstract][Full Text] [Related]
13. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
Robert MC; Biernacki K; Harissi-Dagher M
Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt.
Utine CA; Tzu JH; Akpek EK
Ocul Immunol Inflamm; 2011 Dec; 19(6):413-8. PubMed ID: 22106908
[TBL] [Abstract][Full Text] [Related]
15. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
[TBL] [Abstract][Full Text] [Related]
16. A review of corneal melting after Boston Keratoprosthesis.
Robert MC; Dohlman CH
Semin Ophthalmol; 2014; 29(5-6):349-57. PubMed ID: 25325860
[TBL] [Abstract][Full Text] [Related]
17. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
[TBL] [Abstract][Full Text] [Related]
18. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
[TBL] [Abstract][Full Text] [Related]
19. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis.
Shapiro BL; Cortés DE; Chin EK; Li JY; Werner JS; Redenbo E; Mannis MJ
Cornea; 2013 Jul; 32(7):951-5. PubMed ID: 23591146
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
